Sign inGet started

Pauls Matthew

Insider CIK 1573429 · INSM Chief Commercial Officer · MSTX See Remarks, Director · SLNO Director · PVLA Director · ZCOR Director · SBBP President & CEO, Director · PTHS Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
PTHS Pelthos Therapeutics Inc. S Sale2026-10-022026-10-06786$21.00 $16.5K13,578SEC↗
PTHS Pelthos Therapeutics Inc. S Sale2026-07-022026-07-07692$26.00 $18.0K14,458SEC↗
PTHS Pelthos Therapeutics Inc. S Sale2026-07-022026-07-0794$27.36 $2.6K14,364SEC↗
PVLA PALVELLA THERAPEUTICS, INC A Award deriv2026-06-292026-07-016,000— $06,000SEC↗
SLNO SOLENO THERAPEUTICS INC D To issuer deriv2026-05-182026-05-189,063— $00SEC↗
SLNO SOLENO THERAPEUTICS INC D To issuer2026-05-182026-05-1810,491— $00SEC↗
PTHS Pelthos Therapeutics Inc. S Sale2026-04-022026-04-06415$20.52 $8.5K15,521SEC↗
PTHS Pelthos Therapeutics Inc. S Sale2026-04-022026-04-06371$21.36 $7.9K15,150SEC↗
SVRA Savara Inc G Gift2025-12-162025-12-16128,995— $01,188,050SEC↗
SVRA Savara Inc F Tax w/h2025-12-142025-12-16195,705$6.92 $1.35M1,317,045SEC↗
SVRA Savara Inc G Gift2025-12-102025-12-1123,629— $01,512,750SEC↗
PTHS Pelthos Therapeutics Inc. G Gift2025-12-102025-12-129,542— $01,074SEC↗
PTHS Pelthos Therapeutics Inc. M Exercise deriv2025-10-022025-12-122,123— $014,862SEC↗
PTHS Pelthos Therapeutics Inc. M Exercise2025-10-022025-12-122,123— $010,616SEC↗
PTHS Pelthos Therapeutics Inc. A Award2025-07-022026-04-0125,478— $025,478SEC↗
PTHS Pelthos Therapeutics Inc. M Exercise deriv2025-07-022025-12-128,493— $016,985SEC↗
PTHS Pelthos Therapeutics Inc. M Exercise2025-07-022025-12-128,493— $08,493SEC↗
PTHS Pelthos Therapeutics Inc. A Award deriv2025-07-022025-07-0777,640— $077,640SEC↗
PTHS Pelthos Therapeutics Inc. A Award deriv2025-07-022025-07-0725,478— $025,478SEC↗
SLNO SOLENO THERAPEUTICS INC A Award2025-06-052025-06-093,991— $010,491SEC↗
SLNO SOLENO THERAPEUTICS INC M Exercise deriv2025-03-282025-03-315,937— $09,063SEC↗
SLNO SOLENO THERAPEUTICS INC S Sale2025-03-282025-03-315,937$71.55 $424.8K6,500SEC↗
SLNO SOLENO THERAPEUTICS INC M Exercise2025-03-282025-03-315,937$4.60 $27.3K12,437SEC↗
SVRA Savara Inc S Sale2024-12-162024-12-1654,702$3.31 $181.1K1,536,379SEC↗
SVRA Savara Inc F Tax w/h2024-12-132024-12-1692,593$3.21 $297.2K1,591,081SEC↗
SVRA Savara Inc A Award deriv2024-12-122024-12-16900,000— $0900,000SEC↗
SVRA Savara Inc A Award2024-12-122024-12-16400,000— $01,683,674SEC↗
SLNO SOLENO THERAPEUTICS INC A Award2024-06-062024-06-106,500— $06,500SEC↗
SVRA Savara Inc G Gift2023-12-282023-12-2919,000— $01,283,674SEC↗
SVRA Savara Inc S Sale2023-12-282023-12-2984,000$4.71 $395.6K1,302,674SEC↗
SVRA Savara Inc A Award deriv2023-12-142023-12-15225,000— $0225,000SEC↗
SVRA Savara Inc A Award2023-12-142023-12-15450,000— $01,386,674SEC↗
SVRA Savara Inc F Tax w/h2023-12-142023-12-15109,680$4.45 $488.1K936,674SEC↗
SLNO SOLENO THERAPEUTICS INC A Award deriv2023-08-152023-08-1615,000— $015,000SEC↗
SVRA Savara Inc A Award deriv2022-12-132022-12-15700,000— $0700,000SEC↗
SVRA Savara Inc A Award2022-12-132022-12-15325,000— $01,046,354SEC↗
SVRA Savara Inc F Tax w/h2021-12-312022-01-0362,318$1.24 $77.3K721,354SEC↗
SVRA Savara Inc A Award deriv2021-12-142021-12-14350,000— $0350,000SEC↗
SVRA Savara Inc A Award2021-12-142021-12-14400,000— $0783,672SEC↗
SVRA Savara Inc P Buy2021-12-082021-12-086,500$1.06 $6.9K383,672SEC↗
SVRA Savara Inc P Buy2021-12-022021-12-0210,000$1.10 $11.0K377,172SEC↗
SVRA Savara Inc P Buy2021-11-192021-11-2210,000$1.11 $11.1K365,022SEC↗
SVRA Savara Inc P Buy2021-11-192021-11-222,150$1.07 $2.3K367,172SEC↗
SVRA Savara Inc P Buy2021-11-182021-11-2210,000$1.10 $11.0K355,022SEC↗
SVRA Savara Inc P Buy2021-08-182021-08-1811,900$1.19 $14.2K345,022SEC↗
SVRA Savara Inc P Buy2021-08-172021-08-1815,000$1.18 $17.7K333,122SEC↗
SVRA Savara Inc P Buy2021-05-212021-05-2410,000$1.63 $16.3K318,122SEC↗
SVRA Savara Inc P Buy2021-04-192021-04-1927,400$1.82 $49.9K308,122SEC↗
SVRA Savara Inc P Buy2021-03-222021-03-2224,100$2.07 $49.9K280,722SEC↗
SVRA Savara Inc P Buy2021-02-222021-02-2328,700$1.74 $49.9K256,622SEC↗
SVRA Savara Inc A Award deriv2020-12-162020-12-17500,000— $0500,000SEC↗
SVRA Savara Inc A Award deriv2020-09-152020-09-15898,639— $0898,639SEC↗
SVRA Savara Inc A Award2020-09-152020-09-15227,272— $0227,922SEC↗
ZCOR Zyla Life Sciences D To issuer2020-05-202020-05-2126,953— $00SEC↗
ZCOR Zyla Life Sciences M Exercise deriv2020-04-232020-04-246,667— $013,333SEC↗
ZCOR Zyla Life Sciences M Exercise deriv2020-04-232020-04-286,667— $013,333SEC↗
ZCOR Zyla Life Sciences F Tax w/h2020-04-232020-04-24952$1.75 $1.7K5,715SEC↗
ZCOR Zyla Life Sciences M Exercise2020-04-232020-04-246,667$1.75 $11.7K6,667SEC↗
ZCOR Zyla Life Sciences M Exercise2020-04-232020-04-286,667$1.75 $11.7K6,667SEC↗
ZCOR Zyla Life Sciences F Tax w/h2020-04-232020-04-281,805$1.75 $3.2K4,862SEC↗
ZCOR Zyla Life Sciences A Award2020-03-042020-03-0513,620— $013,620SEC↗
SVRA Savara Inc A Award deriv2019-12-202019-12-2612,000— $012,000SEC↗
ZCOR Egalet Corp A Award2019-04-232019-04-2420,000— $020,000SEC↗
SBBP Strongbridge Biopharma plc A Award deriv2019-02-202019-02-22400,000— $0400,000SEC↗
SBBP Strongbridge Biopharma plc A Award2019-02-202019-02-2250,000— $072,608SEC↗
SVRA Savara Inc A Award deriv2018-12-132018-12-1412,000— $012,000SEC↗
SBBP Strongbridge Biopharma plc F Tax w/h2018-02-262018-02-2817,392$6.60 $114.8K22,608SEC↗
SBBP Strongbridge Biopharma plc A Award deriv2018-02-052018-02-06350,000— $0350,000SEC↗
SVRA Savara Inc A Award deriv2017-05-252017-05-263,750— $03,750SEC↗
SVRA Savara Inc M Exercise deriv2017-04-272020-09-15650— $00SEC↗
SVRA Savara Inc M Exercise2017-04-272020-09-15650— $0650SEC↗
MSTX Mast Therapeutics, Inc. A Award deriv2017-01-232017-01-2345,535— $045,535SEC↗
MSTX Mast Therapeutics, Inc. A Award deriv2016-06-152016-06-1779,551— $079,551SEC↗
MSTX Mast Therapeutics, Inc. A Award deriv2015-10-292015-11-0264,791— $064,791SEC↗
MSTX Mast Therapeutics, Inc. A Award deriv2015-10-292015-11-0237,794— $037,794SEC↗
INSM INSMED INC A Award deriv2014-06-022014-06-0430,000$12.58 $377.4K30,000SEC↗
INSM INSMED INC A Award deriv2014-01-102014-01-1430,000$20.49 $614.7K30,000SEC↗
INSM INSMED INC A Award deriv2013-05-232013-05-2825,000— $025,000SEC↗
INSM INSMED INC A Award deriv2013-04-012013-04-03100,000— $0100,000SEC↗
INSM INSMED INC A Award deriv2013-04-012013-04-03200,000— $0200,000SEC↗